Pradžia › Narkolepsija › South Carolina
Narkolepsija klinikiniai tyrimai South Carolina
7 tyrimai dėl Narkolepsija ieško dalyvių vietose South Carolina.
Miestai South Carolina
Oficialus tyrimo tekstas (anglų kalba)
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Columbia, South Carolina, Columbia
Renkami dalyviai2/3 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07598708A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Columbia
Renkami dalyviai3 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-03 · NCT07455383A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy (AWAKE)
- Bogan Sleep Consultants, Columbia
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-03 · NCT07540364A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
- Lowcountry Lung and Critical Care PA, Charleston
- Medical University of South Carolina, Charleston
- Bogan Sleep Consultants, LLC, Columbia
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-27 · NCT07675135A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Columbia
Renkami dalyviai2/3 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-08-07 · NCT06767683A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
- Bogan Sleep Consultants, LLC, Columbia
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-14 · NCT07493265A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- North Charleston, South Carolina, North Charleston
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-04-16 · NCT07096674Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.